Position in NBIX
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$6,741
+$1,472 QoQ
Shares Held
40
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#697
of 768 holders
Holding Since
Mar 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026WealthCollab, LLC holds $245,435 across 14 Drug Manufacturers - Specialty & Generic names. NBIX ranks #8 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
113 | $61,226 | |
| 2 | RDY |
Dr Reddys Laboratories Ltd
|
3,987 | $57,771 | |
| 3 | LNTH |
Lantheus Holdings, Inc.
|
300 | $33,282 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
756 | $25,613 | |
| 5 | ALKS |
Alkermes plc.
|
481 | $25,204 | |
| 6 | VTRS |
Viatris Inc
|
928 | $14,736 | |
| 7 | IRWD |
Ironwood Pharmaceuticals Inc
|
1,970 | $8,293 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
This page
|
40 | $6,741 |
All Filings in NBIX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,741 | 40 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $5,269 | 40 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,673 | 40 | Shares | Defined | 2026-01-27 | |
| 2025-09-30 | $5,615 | 40 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $5,027 | 40 | Shares | Defined | 2025-08-15 | |
| 2024-06-30 | $5,369 | 39 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,378 | 39 | Shares | Defined | 2024-05-10 | |
| No filing history on record for this holder in this stock. | ||||||